It must include assessment of nutritional status before treatment to identify patients with malnutrition whose risks may only be mitigated with additional support. Fiorella DiCarlo, RDN, CDN, of FiorellaEatsTV, told Healthline that GLP-1s slow gastric emptying and motility, which causes people to feel full and lose their appetite
Dose and timing should follow a confirmed deficiency and your GPs review, not a fixed course sold in advance
In fact, the FDA warns against using them
Checking for these provides valuable insight into a pharmacys compliance history
If youre intrigued by this approach, treat it as you would any earlystage therapeutic concept: proceed with skepticism, seek real medical oversight, demand evidence of product quality, and define in advance what success and failure look like